LEFLUNOMIDE
{'content': [{'@styleCode': 'bold', 'content': [{'@styleCode': 'bold', '#text': 'These highlights do not include all the information needed to use LEFLUNOMIDE TABLETS safely and effectively. See full prescribing information for LEFLUNOMIDE TABLETS.'}, {'@styleCode': 'bold', 'br': None, '#text': 'LEFLUNOMIDE tablets, for oral use Initial U.S. Approval: 1998'}], 'br': [None, None, None]}, {'@styleCode': 'bold'}], 'br': [None, None]}
753453c5-8a7a-878e-3ce7-1d1edce718a9
HUMAN PRESCRIPTION DRUG LABEL
Dec 14, 2023
Apotex Corp.
DUNS: 845263701
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
LEFLUNOMIDE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (5)
LEFLUNOMIDE
Product Details
FDA regulatory identification and product classification information